pI: 8.5829 |
Length (AA): 768 |
MW (Da): 86039 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 6
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | ME49 merozoite. | Hehl AB |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | VEG Tachyzoite, ME49 Tachyzoite, ME49 Oocyst, ME49 Bradyzoite. | Gregory Fritz HM Sibley/Greg |
Fritz HM | Transcriptomic analysis of toxoplasma development reveals many novel functions and structures specific to sporozoites and oocysts. |
Sibley/Greg | ToxoDB |
Gregory | ToxoDB |
Hehl AB | Asexual expansion of Toxoplasma gondii merozoites is distinct from tachyzoites and entails expression of non-overlapping gene families to attach, invade, and replicate within feline enterocytes. |
Ortholog group members (OG5_128622)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT5G14850 | Alg9-like mannosyltransferase family |
Brugia malayi | Bm1_04640 | Plasmid Maintenance Protein containing protein |
Candida albicans | CaO19.3996 | glycosyl phosphatidylinositol (GPI) synthesis |
Candida albicans | CaO19.11479 | similar to putative alpha mannosyltransferase involved in glycosyl phosphatidylinositol (GPI) synthesis |
Caenorhabditis elegans | CELE_T27F7.4 | Protein T27F7.4 |
Cryptosporidium hominis | Chro.30406 | hypothetical protein |
Cryptosporidium parvum | cgd3_3590 | dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase involved in GPI anchor biosynthesis |
Dictyostelium discoideum | DDB_G0284435 | dolichyl-phosphate-mannose alpha-1,6-mannosyltransferase |
Drosophila melanogaster | Dmel_CG12006 | CG12006 gene product from transcript CG12006-RA |
Echinococcus granulosus | EgrG_000447100 | gpi mannosyltransferase 3 |
Echinococcus multilocularis | EmuJ_000447100 | GPI mannosyltransferase 3 |
Homo sapiens | ENSG00000069943 | phosphatidylinositol glycan anchor biosynthesis, class B |
Leishmania braziliensis | LbrM.35.1330 | GPI alpha-mannosyltransferase III |
Leishmania donovani | LdBPK_361260.1 | GPI anchor biosynthesis protein, putative |
Leishmania infantum | LinJ.36.1260 | GPI alpha-mannosyltransferase III |
Leishmania major | LmjF.36.1200 | GPI alpha-mannosyltransferase III |
Leishmania mexicana | LmxM.36.1200 | GPI anchor biosynthesis protein, putative |
Loa Loa (eye worm) | LOAG_10121 | hypothetical protein |
Mus musculus | ENSMUSG00000079469 | phosphatidylinositol glycan anchor biosynthesis, class B |
Neospora caninum | NCLIV_004260 | hypothetical protein |
Oryza sativa | 4324190 | Os01g0580100 |
Onchocerca volvulus | OVOC11628 | GPI mannosyltransferase 3 homolog |
Plasmodium berghei | PBANKA_1354700 | GPI mannosyltransferase 3, putative |
Plasmodium falciparum | PF3D7_1341600 | GPI mannosyltransferase 3 |
Plasmodium knowlesi | PKNH_1259800 | GPI mannosyltransferase 3, putative |
Plasmodium vivax | PVX_082980 | GPI mannosyltransferase 3, putative |
Plasmodium yoelii | PY01388 | hypothetical protein |
Saccharomyces cerevisiae | YGL142C | Gpi10p |
Schistosoma japonicum | Sjp_0208740 | expressed protein |
Schistosoma japonicum | Sjp_0317350 | IPR005599,Alg9-like mannosyltransferase,domain-containing |
Schistosoma mansoni | Smp_053460 | glycosyltransferase |
Schmidtea mediterranea | mk4.001535.07 | |
Schmidtea mediterranea | mk4.001229.02 | GPI mannosyltransferase 3 |
Schmidtea mediterranea | mk4.001535.03 | GPI mannosyltransferase 3 |
Trypanosoma brucei gambiense | Tbg972.10.6760 | GPI anchor biosynthesis protein, putative |
Trypanosoma brucei | Tb927.10.5560 | GPI alpha-mannosyltransferase III |
Trypanosoma congolense | TcIL3000_10_4690 | GPI anchor biosynthesis protein, putative |
Trypanosoma cruzi | TcCLB.510299.50 | GPI alpha-mannosyltransferase III |
Trypanosoma cruzi | TcCLB.503527.40 | GPI alpha-mannosyltransferase III |
Toxoplasma gondii | TGME49_321660 | mannosyltransferase, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.10.5560 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.5560 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.5560 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.10.5560 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_T27F7.4 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_T27F7.4 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_T27F7.4 | Caenorhabditis elegans | larval lethal | wormbase |
CELE_T27F7.4 | Caenorhabditis elegans | slow growth | wormbase |
YGL142C | Saccharomyces cerevisiae | inviable | yeastgenome |
PBANKA_1354700 | Plasmodium berghei | Essential | plasmo |
TGME49_321660 this record | Toxoplasma gondii | Probably essential | sidik |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.